Our results demonstrated that mice receiving BVax cells from CT2A tumor–bearing donors had significant IgG and IgM staining in the peritumoral region compared with those treated with BVax cells derived from healthy donors or with BNaive cells (Figure 8, A and B). This evidence concerns the gene CD40LG and neoplasm.